SIRPG: A Novel Biomarker for Discriminating Tuberculous vs. Malignant Pleural Effusion - Amsterdam 2025

Biomarkers and prognostication in malignant pleural effusions

Chair(s): Sotirios Zarogiannis, Erasmia Rouka

Session type: Poster session

SIRPG: A Novel Biomarker for Discriminating Tuberculous vs. Malignant Pleural Effusion

Wenbei Peng

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

H3K18 lactylation in cancer-associated fibroblasts drives malignant pleural effusion progression via recruiting TNFR2+Tregs

Qiong Zhou

Poster

Abstract

Baseline dyspnoea predicts benefit in malignant pleural effusion (MPE) patients undergoing therapeutic procedures: a meta-analysis of individual patient data

Syed Hamza Abbas

Poster

Abstract

Role of transthoracic US scores in evaluating efficacy of pleurodesis in malignant pleural effusion patients

Dalia Ezat Elsharawy

Abstract

The association of defective pleural sRAGE production with the recurrence of malignant pleural effusion after medical pleurodesis

Chakchawis Kanokkantapong

Poster

Abstract

Investigating the impact of CMV on outcomes in pleural mesothelioma

Geri Lynch

Poster

Abstract

Transforming growth factor-?1 as a predictor of lung expandability and pleurodesis success in malignant pleural effusion

Jarudul Phocharoen

Poster

Abstract

SIRPG: A Novel Biomarker for Discriminating Tuberculous vs. Malignant Pleural Effusion

Wenbei Peng

Poster

Abstract

Immunotherapy in Malignant Pleura Mesothelioma: Real-world Data from a Tertian hospital in chest diseases.

Ilias Bitsas

Poster

Abstract

Immune-molecular retyping (IMR) in NSCLC progression with medical thoracoscopy (MT): a valid option?

Giulia Bartolucci

Poster

Abstract

Beyond NSCLC and IMT: therapeutically targetable ALK rearranged malignant mesenchymal tumors in the thoracic region

Sameer Puri

Poster

Abstract

Pleural liquid biopsy: A non-invasive adjunct to tissue biopsy for molecular profiling

Padraig Ridge

Poster

Abstract

Single-Cell Transcriptomics Identifies T Cell Exhaustion and STAT1 Loss as Hallmarks of Malignant Pleural Effusion Progression

Wenbei Peng

Poster

Abstract

Validation and diagnostic value of emerging ratios and indicators in classification of pleural effusion compared to Lights criteria

Léo Franchetti

Poster

Abstract

Prognostic assessment of malignant pleural effusion in the era of new targeted systemic oncologic treatments

Raphael Freitas Jaber De Oliveira

Poster

Abstract

Gene expression of IL33-ST2 interactome in patients with pleural mesothelioma reveals a role for AMPH gene

Ourania Kotsiou

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}